Cargando…
Drug screening against F13 protein, the target of tecovirimat, as potential therapies for monkeypox virus
Autores principales: | Chen, Zhang-Ren, Lv, Qiao-Li, Peng, Hong-Wei, Liu, Xiao-Yi, Hu, Wen-Lei, Hu, Jin-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694522/ https://www.ncbi.nlm.nih.gov/pubmed/36442658 http://dx.doi.org/10.1016/j.jinf.2022.11.018 |
Ejemplares similares
-
Monkeypox treatment: Is tecovirimat the answer?
por: Niaz, Faizan, et al.
Publicado: (2022) -
Can a smallpox drug treat monkeypox? Compassionate use of tecovirimat for monkeypox infection
por: Fatima, Maurish, et al.
Publicado: (2023) -
Tecovirimat for monkeypox
por: Halani, Sheliza, et al.
Publicado: (2022) -
Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
por: Ali, Yasir, et al.
Publicado: (2023) -
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital
por: Mondi, Annalisa, et al.
Publicado: (2023)